Email Marketing · Biotech & Life Sciences
Email Marketing for Biotech & Life Sciences
Lifecycle email, retention automation, deliverability engineering, and revenue-attributed email programs across Klaviyo, HubSpot, Iterable, Customer.io. Investor relations, scientific communications, and growth marketing for biotech, pharma, medtech, and life sciences companies.
Book a 15-min strategy callThe Biotech & Life Sciences context
What email marketing means for biotech & life sciences companies
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof.
Empire325 email marketing services combine lifecycle program design (welcome, onboarding, nurture, retention, win-back), deliverability engineering (SPF/DKIM/DMARC, sender reputation, list hygiene), and revenue attribution tied to the data warehouse.
Biotech & Life Sciences is a regulated sector, which materially changes how email marketing engagements have to be structured. Empire325 operates within the applicable compliance framework (U.S. Food and Drug Administration guidance, supervisory review, and documented approval workflows) rather than around it. Programs are co-designed with your compliance counsel and chief compliance officer so that creative, distribution, measurement, and reporting all survive an audit. This is materially different from generic agency engagements that treat compliance as an afterthought and produce campaigns that get retroactively pulled or restricted.
For the canonical industry framing, see U.S. Food and Drug Administration — Empire325 references that source-of-truth when building the measurement, attribution, and compliance baseline for every biotech & life sciences email marketing engagement. The methodology layer above it draws on Litmus and our own production patterns from prior biotech & life sciences engagements.
Capabilities
Email Marketing capabilities for biotech & life sciences clients
Why Empire325
Why Empire325 for biotech & life sciences email marketing
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
Measured outcomes
What biotech & life sciences clients achieve
30-50% email-attributed revenue lifts
85-95% inbox placement rates
Compliance: GDPR, CCPA, CASL, SEC Marketing Rule
Revenue per recipient tied to actual orders/conversions
FAQ — Email Marketing for Biotech & Life Sciences
Does Empire325 provide email marketing for biotech & life sciences companies?
Yes. Empire325 delivers email marketing specifically calibrated for biotech & life sciences companies. Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications.
What makes email marketing different for biotech & life sciences vs. other industries?
Biotech marketing in 2026 must respect SEC fair disclosure rules, FDA promotional restrictions, clinical trial blackout periods, and MLR (Medical/Legal/Regulatory) review processes. Long timelines (pre-clinical to commercial: 7-15 years) require sustained narrative investment without short-term traffic metrics as proof. Empire325 applies email marketing methodology with these industry-specific constraints and opportunities built in — not as an afterthought.
How much does email marketing cost for biotech & life sciences companies?
Email Marketing engagements for biotech & life sciences clients typically range from $10K–$60K monthly retainers depending on scope, team size, and market reach. Empire325 provides written scoping after a 30-minute discovery call. Most engagements deliver first measurable outcomes within 60–90 days.
Why choose Empire325 for biotech & life sciences email marketing?
Empire325 biotech marketing combines IR, scientific communications, KOL engagement, and commercial-readiness marketing — built alongside your regulatory and legal counsel. Scientific accuracy under MLR review, Reg-FD-aligned investor communications. Empire325's email marketing practice combines technical depth with biotech & life sciences-specific domain knowledge — so the work lands in your market, not just in a generic framework.
References & further reading
Sources cited on this email marketing for biotech & life sciences page
- Litmus — Litmus 2025 State of Email survey on deliverability, engagement, and revenue per send.
- U.S. Food and Drug Administration — FDA Center for Drug Evaluation and Research promotional-communications guidance.
- Harvard Business Review — Harvard Business Review research on industry-specific marketing strategy and ROI benchmarks.
Need email marketing for your biotech & life sciences company?
15-minute strategy call. No deck, no pitch — specific recommendations based on your context.
Book a 15-min strategy call